A transgenic mouse model study demonstrated that a gain-of-function mutation of the ASXL1 gene resulted in an MDS-like condition in the mice, suggesting a molecular interaction with bromodomain containing 4 (BRD4) [94]. This evidence concerns the gene BRD4 and myelodysplastic syndrome.